ResearchAXGN

AXGN: FY25 Deep Dive

Ddrillr ResearchOriginal research

Published Sep 3, 20261 min read

Summary

Axogen FY25 at $225M. NI $-16M; EPS $-0.34. Medical Devices — Pre-profit.

FY25 revenue $225M; OI $-8M; NI $-16M; EPS $-0.34.

Axogen FY25 (Dec 31, 2025) at $225M revenue. OpInc $-8M; NI $-16M; EPS $-0.34. Medical Devices — Pre-profit.